Develops implants for spine fusion surgery in patients with degenerative disc disease.
Jun 2026Revenue $63.3M/yrExpenses $102M/yr
No trendCash runway ≈ 2.0 years from Jun 2026
Figures by year
When will Carlsmed be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $63.3M and expenses $102M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $50.5M | $81.1M | −$30.6M |
| Dec 2024 | $27.2M | $51.3M | −$24.1M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.